Literature DB >> 21690478

Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitis.

Hisato Kawakami1, Koji Sugioka, Kimio Yonesaka, Taroh Satoh, Yoshikazu Shimomura, Kazuhiko Nakagawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21690478     DOI： 10.1200/JCO.2011.35.0694

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Ocular Toxicity of Targeted Anticancer Agents.

Authors:  Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal:  Drugs       Date:  2021-03-31       Impact factor: 9.546

2.  Corneal Perforation during Combination Chemotherapy including Cetuximab in a Patient with a History of Herpetic Keratitis.

Authors:  Keiichi Aomatsu; Koji Sugioka; Aya Kodama-Takahashi; Masahiko Fukuda; Hiroshi Mishima; Shunji Kusaka
Journal:  Case Rep Oncol Med       Date:  2020-07-07

3.  Administration of Menadione, Vitamin K3, Ameliorates Off-Target Effects on Corneal Epithelial Wound Healing Due to Receptor Tyrosine Kinase Inhibition.

Authors:  Jamie S Rush; David P Bingaman; Paul G Chaney; Martin B Wax; Brian P Ceresa
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

4.  Knockout of c-Cbl slows EGFR endocytic trafficking and enhances EGFR signaling despite incompletely blocking receptor ubiquitylation.

Authors:  Brandon L M Crotchett; Brian P Ceresa
Journal:  Pharmacol Res Perspect       Date:  2021-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.